Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-24 @ 9:58 PM
NCT ID:
NCT02261532
Eligibility Criteria:
Inclusion Criteria:
* 1\. Has provided written informed consent prior to performance of any study procedure.
* 2\. Has definitive histologically or cytologically confirmed advanced or metastatic solid tumor.
* 3\. Is able to take medications orally.
* 4\. Has adequate organ function (bone marrow, kidney and liver).
* 5\. Has Eastern Cooperative Group (ECOG) performance status of 0 or 1.
Exclusion Criteria:
* 1\. Has received TAS-102.
* 2\. Has suffered serious complications.
* 3\. Has unresolved toxicity of greater than or equal to CTCAE Grade 2 attributed to any prior therapies.
* 4\. Has had prior gastrectomy.
* 5\. Is a pregnant or lactating female or male who refused using birth control during the clinical trial period and within 6 months after discontinuation of study treatment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02261532
Study Brief:
Protocol Section:
NCT02261532